The page is the record's research on the issuer — no analyst, no rating, no view.

# Xenetic Biosciences, Inc. (NASDAQ: XBIO) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Xenetic Biosciences, Inc., listed on NASDAQ under ticker XBIO, with ISIN US9840156023 and LEI 5493002WV0KYX8JXAH52. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Nevada. Its segment is not on the record. Its listing status is listed, not halted.

## The disclosure read

The record holds 24 filings across 19 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 10.0 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. The latest filing is dated 2026-09-23 and is of type corporate_news, which is 46 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days. The NASDAQ median filing count is 52 and the sector median filing count is 63.0. By type, the window holds 9 results, 5 directors_dealings, 4 corporate_news, 4 regulatory_filing, 1 agm_egm and 1 director_change filing.

## Auditor

The auditor of record is CBIZ CPAs P.C., located in Hartford, CT. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

## Open research

No openly published research notes were found. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The record is sealed for the issuer in the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001534525.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/XBIO (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1534525/000168316826001737/xenetic_i10k-123125.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/XBIO (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/XBIO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp